The production of IL-1, IL-6, IL-8, and granulocyte macrophage colony-stimulating factor is inhibited when TNF-α is neutralised [32], a discovery that has led to the emergence of anti-TNF-α therapy in RA [39]. The gene discussed is CXCL8; the disease is rheumatoid arthritis.